trending Market Intelligence /marketintelligence/en/news-insights/trending/X6I9kd6bqWMNfmdVRimu2w2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Drug development services provider PPD files for $100M IPO

Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive

South State CenterState MOE Shows Even The Strong Need Scale To Thrive

Talking Bank Stocks, Playing The M&A Trade With Longtime Investor

Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible


Drug development services provider PPD files for $100M IPO

PPD Inc., a Wilmington, N.C.-based provider of drug development services, filed for an IPO of its common stock to raise up to $100 million.

The contract research organization — led by chairman and CEO David Simmons — plans to list its shares on the Nasdaq Global Select Market under the ticker symbol PPD.

Hellman & Friedman LLCPPD, formerly known as Eagle Holding Co. I, was formed as a corporation in Delaware on April 13, 2017. It is a holding company with no material direct operations, and its principal assets are the Eagle Holding Co. II common shares that it holds.

Eagle Holding Co. II is the indirect parent of Pharmaceutical Product Development LLC, which, together with its subsidiaries, owns substantially all of PPD operating assets.

Private equity investment firms Hellman & Friedman LLC and Carlyle Group LP are among the sponsors of PPD with 56.7% and 23.8% stakes, respectively.

PPD plans to use net proceeds from the offering coupled with cash on hand to redeem $550 million of notes issued by Eagle Holding Co. II in May 2017 and to redeem $900 million of notes issued by Eagle Holding Co. II in May 2019.

Barclays, J.P. Morgan Securities LLC., Morgan Stanley & Co. LLC, Goldman Sachs & Co. LLC, BofA Securities LLC, Credit Suisse Securities LLC, Jefferies LLC, UBS Securities LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Evercore Group LLC, HSBC Securities Inc., Mizuho Securities, Robert W. Baird & Co. Inc. and William Blair & Co. LLC are the underwriters on the IPO.